4th Annual Conference on Psychedelics and Psychedelic Medicine

4^th Annual Conference on Psychedelics & Psychedelic Medicine

Program Agenda

November 15-16, 2024

Day 1 – November 15, 2024

8:00-8:05 AM             Welcome and Introduction

Franklin King, MD

MODULE TOPIC 1: Background, Pharmacology, & Keynote

8:05–8:30 AM            A Brief History of Psychedelics

Franklin King, MD

8:30-8:55 AM              Pharmacology

Franklin King, MD

8:55-9:40 AM             The Psychedelic Mainstreaming Train Temporarily Derailed

                                       Rick Doblin, PhD

9:40-9:55 AM              Question & Answer (No Slides)

Moderator: Jerrold F. Rosenbaum, MD

Discussant: Rick Doblin, PhD

9:55-10:10 AM             Break

MODULE TOPIC 2:  Risks, Harms and Conceptual Challenges

10:10-10:35 AM           From Efficacy to Effectiveness: Towards Reliable Evidence-Based Policy for Psychedelic Therapies

  Eduardo Schenberg, PhD                                  

10:35-11:00 AM           Risks and Harms in Psychedelics and Psychedelic-Assisted Therapies

  Alden Doerner Rinaldi, MD

11:00-11:25 AM          Tripping in No-Place: How Place Shapes Meaning in Psychedelic-Assisted Therapy (No Slides)

  Tristan Angieri, MArch, MTS Candidate

11:25-11:55 AM           Panel Discussion (No Slides)

                                        Moderator: Franklin King, MD

  Panelists: Rachel Peterson, MD, Alden Doerner Rinaldi, MD, Eduardo Schenberg, PhD.

11:55-12:55 PM           Lunch Break (on your own)

MODULE TOPIC 3: Psychedelics & Psychosomatics

12:55-1:25 PM             Psychedelic-Assisted Therapies and Serious Medical Illness

Roxanne Sholevar, MD, Zachary Sager, MD, Yvan Beaussant, MD

1:25-1:50 PM               Psilocybin in Functional Medical Disorders: A Pilot Study in Irritable Bowel Syndrome

Erin Mauney, MD; Franklin King, MD

1:50-2:20 PM              Panel Discussion (No Slides)

Moderator: Jerrold F. Rosenbaum, MD

Panelists: Erin Mauney, MD, Roxanne Sholevar, MD, Zachary Sager, MD, Yvan Beaussant, MD, Franklin King, MD

MODULE TOPIC 4: Psychedelic-Assisted Psychotherapy

2:20-2:45 PM              Reflections from Psychedelic-Assisted Psychotherapy Using Ketamine and MDMA 

            Elizabeth Call, PhD

2:45-3:10 PM              What’s Therapy Got to Do With It?

            Michael Alpert, MD

3:10-3:35 PM               Music and Your Mind: Approach to Music in Psychedelic Therapy Sessions

Lisa Summer, PhD

3:35-4:05 PM              Panel Discussion (No Slides)

  Moderator: Franklin King, MD

                                    Panelists: Elizabeth Call, PhD, Michael Alpert, MD, Lisa Summer, PhD

4:05-4:15 PM              Break

4:15 – 5:15 PM             Friday Breakout Seminars:

The Neurobiology of Plant Medicine: Leveraging 21^st Century Approaches to Ethnobotany

Stephen Haggarty, PhD

Psychedelics and Psychosis: Phenomenological Differences and Overlaps

Haley Maria Dourron, PhD

Decolonizing the Medicalization of Psychedelics

Christine Hauskeller, PhD

Day 2 – November 16, 2024

8:00-8:05 AM              Welcome & Introduction

Franklin King, MD

MODULE TOPIC 5:  Neuroscience of Psychedelics

8:05-8:30 AM              Simultaneous Imaging of Clinicians and Participants with Fibromyalgia: Perspectives and Results from the MDMA Hyperscan Study

                                       Vitaly Napadow, PhD

8:30-8:55 AM              The Effects of Psilocybin on Cognition                                                                                  

       Ceyda Sayali, PhD

8:55-9:20 AM              Cognitive Neuroscience of Psychedelics                                         

       Alfred Kaye, MD, PhD

9:20-9:50 AM              Panel Discussion (No Slides)

            Moderator: Bruce Rosen, MD, PhD

                                    Panelists: Ceyda Sayali, PhD, Alfred Kaye, MD, PhD, Vitaly Napadow, PhD

9:50-10:05 AM            Break

MODULE TOPIC 6: Ketamine 

10:05-10:25 AM           Ketamine-Assisted Psychotherapy – Inpatient Treatment of the Future? 

 Fernando Espi Forcen, MD

10:25-10:50 AM            Ketamine and Esketamine for Major Depression

 Cristina Cusin, MD

10:50-11:20 AM            Panel Discussion (No Slides)

 Moderator: Franklin King, MD

 Panelists: Cristina Cusin, MD, Fernando Espi Forcen, MD

MODULE TOPIC 7:  Clinical Applications of Psychedelics  

11:20-11:45 AM           Psilocybin-Assisted Therapy for Depression: A Critical Look at the Evidence

                                        Kelley O’Donnell, MD

11:45-12:05 PM           Amplifying PTSD Treatments with MDMA  

Anne Wagner, PhD

12:05-12:25 PM          Psychedelics and Addictions: Psilocybin for Cocaine Use Disorder 

Brian Barnett, MD  

12:25-12:55 PM          Panel Discussion (No Slides)

            Moderator: Franklin King, MD

Panelists: Kelley O’Donnell, MD, Anne Wagner, PhD, Brian Barnett, MD  

12:55-1:55 PM             Lunch Break (on your own)

Ticketed Lunch Workshop – Building a Psychedelic-Assisted Therapy Practice (No Slides)

                                       Albert Yeung, MD; Maren Nyer, PhD; Elizabeth Call, PhD; Francis Guerriero, MA, LICSW

MODULE TOPIC 8:  Structural and Systemic Issues in Psychedelics 

1:55-2:20 PM              Challenging Structural Racism in Psychedelic Research

Darron Smith, PhD

2:20-2:45 PM              Psychedelics and the Law (No Slides)

Mason Marks, MD, JD

2:45-3:15 PM              Panel Discussion (No Slides)

Moderator: Franklin King, MD

Panelists: Mason Marks, MD, JD, Darron Smith, PhD

3:15-3:30 PM             Break

MODULE TOPIC 9:  Challenges of Implementation

3:30-3:55 PM              How to Educate Clinicians on Psychedelics? (No Slides)                                         

      Janis Phelps, PhD, Franklin King, MD, Roxanne Sholevar, MD

3:55-4:20 PM              Who’s Going to Pay for All This? Navigating the Challenges of Psychedelic Assisted Therapy Rollout

Brian Barnett, MD

4:20-4:50 PM              Panel Discussion (No Slides)

            Moderator – Franklin King, MD

                                    Panelists: Janis Phelps, PhD, Brian Barnett, MD, Roxanne Sholevar, MD

4:50 PM                      Adjourn